U.S., Jan. 14 -- An application to own the trademark for 'RYTMEC' has been filed on Jul. 31, 2025.
Owner(s):
Taysha Gene Therapies, Inc.; 3000 Pegasus Park Drive, Suite 1430, TEXAS
Goods and/or Services:
For: Pharmaceuticals and pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of neurodevelopmental diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in the treatment of Rett syndrome diseases and disorders; Pharmaceuticals and pharmaceutical preparations for use in intrathecally administered gene therapy treatments
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - S...